breast cancer

DCI and Duke Heart clinicians, the DCI COEE team, and the Quit at Duke team will lead several screening and health education sessions. 

A metastatic breast cancer drug, discovered in the McDonnell Lab, is now FDA-approved—the first new oral endocrine therapy in 20+ years. Another might not be so far behind.

Duke Fencing students are asking the community to Fence4TheFight against breast cancer, in memory of their long-time manager Elizabeth Beguinet.

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

For the first time in three years, cancer patients, survivors, families, friends, clinicians, faculty, and staff gathered in person for the Tree of Hope.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.

Researchers mapping a molecular atlas for ductal carcinoma in situ have developed a predictive model to distinguish which cases will progress.

DCI oncologists — doctors Davidson, Kamal, Moss, Secord, Menendez, and Kelley — blaze a trail, at the national level, in breast & gynecologic cancers.

"What's Best For Breasts? A Conversation with Clinicians" was held online, Oct. 8. Topics included imaging, genetic testing, breast cancer risk, research, survivorship, and more.

A research team led by Ann Marie Pendergast, PhD, found, in animal studies, that a leukemia drug disrupted HER2-positive breast cancer-spread to the brain.

A multi-disciplinary team fortifies a spine metastasis patient with expertise, care, and support, for her best life possible.

John Wayne Cancer Foundation is funding research by breast surgical oncologist Maggie DiNome, MD, to create a molecular-based way to predict cancer spread to lymph nodes.
 

DCI cardio-oncologist Susan Dent, MD, is lead investigator for DCI-enrolled patients in this NIH-funded multi-site breast cancer study.

A DCI study led by Shelley Hwang, MD, MPH, shows the potential of new imaging technology to help avoid repeat surgery after lumpectomy.

Meet the mom and daughter who lit the virtual Tree of Hope at the Duke Cancer Patient Support Programʼs 31st annual Tree of Hope Lighting Ceremony.

Achieving health through advocacy, Duke Consortium for Inflammatory Breast Cancer expands its community outreach with Duke students taking the lead.

DCI study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation

DCI teams raised more than $12,000 for the Susan G. Komen Foundation at the Komen Triangle Race for the Cure on April 30.

"Sometimes we have to go on a journey we don't want to go on. But I'm getting better," said breast cancer survivor Vennice Roberts.

DCI pathologist Jeffrey Marks, PhD, has been named "Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery."

"Survivor Friendly" began in 2016 after the founder, Jacqueline Cromity, had more than her fair share of cancer experiences.

DCI health services researcher Devon Check, PhD, is co-PI on an NIA grant to study risks of co-prescribed opioids & BZDs in older cancer patients.

Breast cancer surgeons help patients in rural areas access services and care.

Donald McDonnell, PhD, associate director for Translational Research, DCI, receives prestigious St. Patrick's Day Irish science medal for contributions to academia and industry.

About one in seven breast cancers detected by mammography screening are over-diagnosed, according to a Duke Cancer Institute study

For Melinda Rittenhouse, an MBC survivor & member of an artists' collective that recently exhibited their work at Duke Hospital, the fact it was here "meant even more."

The Eighth Annual DCI Scientific Retreat was one for the books.

Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.

The grandfather of breast surgical oncologist Hannah Woriax, MD, was the first Native American to graduate from the Duke Med School and train in Family Medicine.

On Feb. 2 at noon, the Southeastern American Indian Cancer Health Equity Partnership hosts DCI breast surgeon Hannah Woriax, MD, for a virtual lecture (with CME credit available).

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.

Join faculty speakers from the DCI Breast Cancer Disease Group on Oct. 26 for an virtual OncLive breast cancer webinar.

In October, the DCI Office of Health Equity & the Mexican Consulate in Raleigh brought awareness to breast, uterine, and cervical cancer detection and prevention.

Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.

Haley Moss, MD, MBA, will work to expand access to care for women veterans through teleoncology and clinical trials in new role at the U.S. Dept. of Veterans Affairs.

A DCI breast cancer care team joins forces with a genetics counselor to treat mother with high-risk genetic syndrome; prompting testing and preventative screening for her kids.

The 8^th Annual DCI Scientific Retreat will be held via Zoom on Friday, Dec. 3, 2021 from 12:30 p.m. to 5 p.m. Keynote: UCSF's Alan Ashworth, PhD, FRS.

The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.

Jen Eaton, MD, was a textbook example of a woman at low risk for breast cancer.

"What's Best For Breasts? A Conversation with Duke Clinicians" was held online on Oct. 2. Topics included imaging, genetic testing, breast cancer risk assessment & prevention.

The gloves are on in the fight against breast cancer. See you at sunrise, Oct. 23 !

For Breast Cancer Awareness Month, Duke Women's Cancer Care Raleigh to host community event with mammograms and activities centered on women's health, Oct. 9.

New study on cholesterol and breast cancer finds link between high cholesterol and worsening cancer spread.

Shelley Hwang, MD, vice chair of Research in the Department of Surgery, is renowned for her work in pre-invasive breast cancer.

Donald McDonnell, PhD, has been awarded a $600K Susan G. Komen Grant to study a potential new treatment for metastatic ER-positive breast cancer.

After 32 years with the Duke Cancer Institute family, breast medical oncologist P. Kelly Marcom, MD, retired from clinical practice at the end of May.

Duke University Hospital Honored oncology nurse Taylor Jones with the hospital's first DAISY Award for extraordinary nurses.

DCI oncologists and researchers are supporting the Komen mission “for a cure” — fighting breast cancer on all fronts. Learn about their research.